Home > Insider Trading > Filing (0001062993-22-024440)

Filing Details

Accession Number:: 0001062993-22-024440
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-23 10:18:11
Reporting Period:: 2022-12-21

Accepted Time:: 2022-12-23 10:18:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
49071	Humana Inc	HUM	Hospital & Medical Service Plans (6324)	610647538

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1025393	Jr/Ky A David Jones	Chrysalis Ventures, Inc. 101 S. Fifth Street, Suite 1650 Louisville KY 40202		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Humana Common	Disposition	2022-04-28	11,300	$0.00	57,028	No	4	G	Indirect	See Footnote
Humana Common	Disposition	2022-12-21	15,000	$501.72	42,028	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	G	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Humana Common	412	Direct
Humana Common	800	Indirect	See Footnote

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Humana Common	Restricted Stock Units	$0.00			5,892	5,892	Direct
Humana Common	Restricted Stock Units	$0.00			95	95	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
	5,892	5,892	Direct
	95	95	Direct

Footnotes

Shares held in two trusts for the benefit of reporting person's son/daughter, respectively, in each case where the reporting person is the sole trustee.
Annual Director's fee payable in stock units which have been deferred at the election of the reporting person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).
Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan until his resignation of services as a director at which time the deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule16(b)-3(d).
Shares held by a revocable trust account (Dec 2009), on which reporting person is the sole trustee, holding certain shares of Humana Inc. common stock.
Includes 412 restricted stock units pursuant to the annual Director's Fee Program representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan of which 100% is vesting on 12/31/22.
Shares disposed of represent gift/charitable donation effective April 28, 2022, in which no value was received in return.
Shares contributed by the David Jones Jr Revocable Trust to an exchange fund in return for shares of the exchange fund. The Humana Inc. common stock was valued at $501.72 per share, using close of business prices on the day prior to the exchange date, for purposes of determining the number of shares of the exchange fund issued to the Revocable Trust.